Evkeeza (evinacumab or evinacumab-dgnb) is a monoclonal antibody that treats homozygous familial hypercholesterolemia (HoFH), a rare genetic condition that causes extremely high cholesterol levels. It's an add-on medication for adults and children aged 5 years and older who aren't able to reach their cholesterol goals even with diet changes and other medications. Evkeeza (evinacumab) is given as an infusion through the veins (IV) once a month. Side effects can include dizziness and cold- or flu-like symptoms.
Evkeeza (evinacumab) is a monoclonal antibody that works as an angiopoietin-like 3 (ANGPTL3) inhibitor. ANGPTL3 is a protein in your liver that normally stops your body from getting rid of triglycerides (fat) and low-density lipoprotein (LDL, also known as “bad” cholesterol). By blocking the ANGPTL3 protein, Evkeeza (evinacumab) allows your body to break down and remove triglycerides and LDL.
| Common Brands | Evkeeza |
|---|---|
| Drug Class | ANGPTL3 inhibitor |
| Controlled Substance Classification | Not a controlled medication |
| Generic Status | No lower-cost generic available |
| Availability | Prescription only |
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Evkeeza (evinacumab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Though rare, it's possible to have a serious allergic reaction to Evkeeza (evinacumab). These allergic reactions can include anaphylaxis (closing of the throat), hives, trouble breathing, and swelling of the face or tongue. Your nurse will watch out for allergic reactions during your infusion, but be sure to tell your care team right away if you think you're having an allergic reaction to the medication. Call 911 if it happens after you've left the infusion center or clinic or when you're at home.
Based on findings from animal studies, Evkeeza (evinacumab) can cause birth defects when it's used during pregnancy. If you’re a woman who can have children, your provider might ask you to take a pregnancy test to make sure you're not pregnant before you start treatment. You'll need to also use reliable birth control during treatment and for at least 5 months after your last dose of Evkeeza (evinacumab). Let your provider know if you’re planning to become pregnant or are currently pregnant. Your provider will help you find safer ways to lower your cholesterol.
Evkeeza (evinacumab) is an intravenous (IV) infusion that's given by a healthcare provider. The typical dose is based on your body weight at 15 mg/kg that's infused IV once a month.
Prescription savings
Stop paying too much for your prescriptions. Compare prices, get pharmacy coupons, and save up to 80%.
Find expert answers to your health questions so you can make the best decisions for yourself and your family.Health conditions
Medications & treatment
Access & affordability
Our monthly healthcare membership can help you save thousands on your prescription costs.Resources
Yes, Evkeeza is FDA approved to treat homozygous familial hypercholesterolemia (HoFH), a rare genetic condition causing extremely high cholesterol levels. It was first approved in 2021 for adults and children 12 years and older. A few years later in March 2023, the FDA approved the medication for younger children (those 5 to 11 years old). The approval means that the FDA reviewed clinical studies with Evkeeza and decided that it works well to lower triglycerides (fats) and LDL ("bad" cholesterol) and is safe to use.
Evkeeza is given as an intravenous (IV) infusion. A healthcare provider will set up an infusion pump to inject the medication into a vein in your arm. The infusion will take about 1 hour to complete. To best prepare for your IV infusion, wear comfortable, loose-fitting clothing allows easy access to your arms and bring snacks or entertainment to help pass the time.
No, Evkeeza is a medication that gets added on to your current medication plan. For people with homozygous familial hypercholesterolemia (HoFH), it can be hard to manage cholesterol levels even with diet changes and other medications. Taking medications from different drug classes at the same time can help you reach your cholesterol goals. This is because each medication in your treatment plan lowers your cholesterol levels by working on different aspects of how cholesterol is either made or removed from your body. Talk to your provider about how Evkeeza fits in with your current treatment plan.
No, Evkeeza is only approved for the treatment of homozygous FH at this time. Talk to your provider about other treatment options if you have another form of FH called heterozygous FH (HeFH).
No, you shouldn't take Evkeeza if you're pregnant or planning on becoming pregnant. The medication might harm your unborn baby. Discuss with your provider to find the best birth control option for you to avoid getting pregnant while you're taking Evkeeza. If you're a woman who can become pregnant, you must use birth control during treatment and for 5 months after your final dose of the medication.
Talk to your provider about the risks and benefits of breastfeeding while you're taking Evkeeza. There's not much information about whether the medication is found in breast milk, whether it causes side effects in babies who nurse, and whether it affects milk supply. Your provider might recommend other ways to feed your baby, such as using formula.
